Adma Biologics reported $400K in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Adma Biologics USD 400K 198K Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Dynavax Technologies USD 7.74M 675K Mar/2025
Takeda 73.76B 81.93B Jun/2025